期刊
TRENDS IN BIOCHEMICAL SCIENCES
卷 33, 期 9, 页码 426-434出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibs.2008.06.005
关键词
-
资金
- Agence Nationale de la Recherche [R0651ONS]
- Association de Langue Francaise pour l'Etude do Diabete et des Maladies Metaboliques
Gain-of-function mutations within proprotein convertase subtilisin kexin type 9 (PCSK9) are linked to familial autosomal dominant hypercholesterolaemia, a disease characterized by elevated plasma concentrations of cholesterol associated with low-density lipoproteins (LDLs). Conversely, PCSK9 loss-of-function mutations result in low levels of LDL cholesterol (LDLC) and protect against coronary heart disease. Although compelling evidence indicates that PCSK9 impairs the LDLR pathway, its role in cholesterol metabolism remains incompletely defined. In the past two years, several new biochemical findings, including the PCSK9 crystal structure and the identification of several transcriptional repressors, were reported. Moreover, new clinical and epidemiological data have revealed the correlation between plasma PCSK9 concentrations and LDLC levels.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据